| IV-95 Shuying Yang Population dose-Hgb modelling of Jesduvroq (daprodustat) across five phase 3 studies in chronic kidney disease patients with anemia Thursday 15:25-16:55 |
| IV-95 Shuying Yang Population dose-Hgb modelling of Jesduvroq (daprodustat) across five phase 3 studies in chronic kidney disease patients with anemia Thursday 15:25-16:55 |